Australia's medical research institutes are a powerhouse, driving economic growth and improving health outcomes, according to a recent report by the Association of Australian Medical Research Institutes (AAMRI). The report, prepared by Nous Group, highlights the significant economic value and national capability of these institutes, with a focus on their role in clinical trials and research translation.
The findings are particularly timely, as they come amidst a critical juncture for Australia's health system and research pipeline. National policy frameworks, such as Ambitious Australia and the National Health and Medical Research Strategy, emphasize the importance of research and development in driving productivity, economic growth, and improved health outcomes. This underscores the need for sustained and strategic investment in health and medical research to secure Australia's future prosperity.
The report reveals that medical research institutes generate an estimated $4.07 billion in annual economic benefit, delivering a return of $3.90 for every dollar invested. Clinical trials, in particular, showcase remarkable value, returning $5.80 for every dollar invested while providing Australian patients with early access to potentially life-saving treatments. This is a testament to the institutes' ability to translate research into practical applications, benefiting both the economy and public health.
AAMRI President Professor Jason Kovacic emphasizes the institutes' dual role as a critical national asset and a catalyst for real-world impact. He states, 'Australia’s medical research institutes deliver far more than discovery alone. They bring together clinicians, scientists, and patients in a way that supports research moving into clinical care, clinical trials, and ultimately better outcomes for patients.' This collaborative approach fosters a strong clinical trials system, encourages industry collaboration, and contributes to long-term economic growth.
The report also highlights the institutes' contribution to highly skilled jobs, the advancement of biotechnology and medical technology industries, and the strengthening of Australia's global research competitiveness. AAMRI CEO Dr. Saraid Billiards underscores the importance of a strong and sustainable medical research institute sector, noting that their independence, strong hospital links, and focus on translation enable efficient research translation into clinical practice and patient care.
However, the report also identifies growing pressure on the funding model underpinning Australia's medical research institutes. Government funding primarily covers direct research costs, while the substantial indirect costs associated with infrastructure, equipment, data systems, and technical staff are only partially funded. As a result, institutes are increasingly subsidizing government-funded research through philanthropy, commercial activity, and internal reserves.
Without changes to the funding model, the analysis projects significant financial sustainability challenges for several institutes over the next decade, potentially jeopardizing Australia's research capacity and future health and economic benefits. Dr. Billiards emphasizes the need for a sustainable funding model that reflects the full cost of research, ensuring institutes can continue delivering essential services, including clinical trials, translation, and workforce development.
Professor Kovacic concludes by emphasizing the potential for Australia's medical research institutes to deliver significant returns with the right support. He states, 'This is one of Australia’s highest-return investments. With the right support, our institutes will continue to deliver breakthroughs that improve lives and strengthen the health system.'
The report provides a comprehensive summary of the findings and the full report, offering valuable insights into the economic and societal impact of Australia's medical research institutes. It serves as a call to action for policymakers to prioritize sustainable funding models and support these institutes in their crucial role in advancing medical research and improving health outcomes.
